Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Resolution. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN104496843B details a low-cost ubenimex synthesis route avoiding toxic resolving agents, offering significant supply chain and purity advantages for pharmaceutical manufacturers.
Patent CN120904158A reveals a novel route for Olanetidine intermediates. Achieve high purity and cost reduction in API manufacturing with scalable solid-state processes.
Patent CN103435532A details a low-cost synthesis of Boceprevir intermediates. Discover how this novel route eliminates precious metal catalysts for superior supply chain reliability.
Patent CN102321040A details a low-cost resolution method for Linezolid intermediates using chiral acids, offering significant supply chain advantages for API manufacturers.
Advanced one-step resolution technology for high-purity Lacosamide intermediates. Discover cost-effective manufacturing and reliable supply chain solutions for chiral pharmaceutical compounds.
Patent CN110643670A details a high-yield chemoenzymatic route for D-glutamine production, offering significant cost reduction in pharmaceutical manufacturing and scalable supply solutions.
Novel enzymatic resolution method for chiral spiro compounds. Reduces cost and improves supply chain reliability for pharmaceutical manufacturing.
Patent CN107778234A enables high-purity neuromuscular blocker synthesis. This process reduces cost and improves supply chain reliability for global pharmaceutical intermediates.
Novel chiral resolution method ensures high purity and cost efficiency. Reliable supply chain for pharmaceutical intermediates manufacturing with optimized resolving agent recovery.
Patent CN104496806B reveals high-yield synthesis for chiral selectors. Enhances supply chain reliability and reduces manufacturing costs for pharmaceutical intermediates.
Advanced synthesis of 3-benzazepines via novel cyclization and reduction routes. Offers cost reduction in API manufacturing and scalable production for CNS disorder treatments.
Patent CN109762768B details a novel Bacillus B8W22 strain for producing high-purity pharmaceutical intermediates with superior stereoselectivity and reduced environmental impact.
Patent CN112979701A details a novel nickel-catalyzed resolution for L-glufosinate-ammonium. Achieve >95% yield and ee value with significant cost reduction in agrochemical manufacturing.
Patent CN113242854B reveals novel chiral resolution for S-IOBA. Enhances supply chain reliability and reduces manufacturing costs for agrochemical intermediates significantly.
Patent CN100385007C details a microbial method for (R)-mandelic acid using Brevibacterium flavum, offering high optical purity and scalable biocatalysis for pharma intermediates.
Novel chemical resolution method for 1-R-3-fluoropiperidine-4-carboxylic acid replacing expensive chromatography with scalable Mitsunobu esterification.
Patent CN109232220B details a novel chiral resolution method offering high purity and scalable production for pharmaceutical intermediate supply chains.
Patent CN111440121B reveals a high-efficiency chiral resolution method for Tetrandrine intermediates, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Advanced resolution technology for Edoxaban precursor ensuring >99% ee. Optimized for cost-effective API manufacturing and reliable supply chain continuity.
Novel base-catalyzed racemization of larotrectinib intermediate enables recycling of S-isomer, reducing costs and waste for API manufacturing.